動画検索
関連広告
検索結果
The significance of the FDA approval of lenvatinib (Lenvima) as a first-line treatment option for patients with unresectable hepatocellular ...
YouTube-OncLiveTV
2018/12/20Panelists R. Michael Tuttle, MD; Eric Sherman, MD; Marcia S. Brose, MD; Naifa Busaidy, MD, FACP, FACE; and Frank Worden, MD; ...
YouTube-OncLiveTV
2016/05/25動画の見どころ1/10枚目 Lenvatinib Phase II Study
動画の見どころ2/10枚目 Lenvatinib Phase 3 Study
動画の見どころ3/10枚目 Primary outcome: progression-free survival
動画の見どころ4/10枚目 Conclusion
動画の見どころ5/10枚目 Overall survival analysis
動画の見どころ6/10枚目 Lenvatinib side effects
動画の見どころ7/10枚目 Lenvatinib and muscle loss
動画の見どころ8/10枚目 Muscle and weight loss
動画の見どころ9/10枚目 What is the mechanism of weight loss?
動画の見どころ10/10枚目 Myocardial infarction and pulmonary emboli
Richard Finn, MD, associate professor of medicine, University of California, Los Angeles David Geffen School of Medicine, discusses the role ...
YouTube-OncLiveTV
2018/09/19Lenvatinib with pembrolizumab were found to be the efficacious treatment option and had similar overall survival outcomes compared to other ...
YouTube-VJOncology
2024/02/09Matthew H. Taylor, MD and R. Michael Tuttle, MD, provide a synopsis of the SELECT trial.
YouTube-OncLiveTV
2015/05/07Lori J. Wirth, MD, associate professor, Medicine, Harvard Medical School, medical director, Center for Head and Neck Cancers, ...
YouTube-OncLiveTV
2018/06/18Listen to a soundcast of the August 10, 2021 FDA approval of Lenvima (lenvatinib) in combination with Keytruda (pembrolizumab) for ...
YouTube-U.S. Food and Drug Administration
2024/04/02lenvatinib (Lenvima) in combination with pembrolizumab (Keytruda) as treatment of patients with metastatic anaplastic or poorly ...
YouTube-Targeted Oncology
2020/09/19What is the clinical impact of these results? What it tells us is that lenvatinib/pembrolizumab is working irrespective of the tumour load that ...
ecancer
2024/01/30The significance of the FDA approval of lenvatinib (Lenvima) as a first-line treatment option for patients with unresectable hepatocellular ...
YouTube-OncLiveTV
2018/12/20Matthew H. Taylor, MD, discusses dosing adjustments for patients on lenvatinib.
YouTube-OncLiveTV
2015/05/07... lenvatinib in patients with radioactive iodine-refractory differentiated thyroid cancer. The study compared starting doses of 24mg and 18mg ...
YouTube-VJOncology
2021/06/08Kathleen Moore, MD, from the University of Oklahoma Stephenson Cancer Center in Oklahoma City, OK, discusses Lenvatinib (LEN) and ...
YouTube-Society of Gynecologic Oncology
2019/10/01Dr Bradley McGregor speaks to ecancer about the CLEAR study which explores lenvatinib plus pembrolizumab compared to sunitinib in patients ...
ecancer
2022/09/12Matthew H. Taylor, MD, discusses dosing adjustments for patients on lenvatinib.
YouTube-OncLiveTV
2015/05/07Marcia Brose, MD, PhD, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, shares the results of a recent Phase ...
YouTube-VJOncology
2021/06/08... role of lenvatinib and the efficacy and safety results with lenvatinib in combination with everolimus in advanced renal cell carcinoma.
YouTube-OncLiveTV
2016/08/12Thomas Hutson, DO, PharmD, FACP; James J. Hsieh, MD, PhD; and Martin H. Voss, MD, share their personal experience using ...
YouTube-OncLiveTV
2017/08/02... lenvatinib in combination with pembrolizumab versus sunitinib in patients with advanced renal cell carcinoma (aRCC). Longer follow-up data ...
YouTube-VJOncology
2022/09/11A roundtable discussion, moderated by Monty Pal, MD, of the City of Hope, focused on updates in renal cell carcinoma (RCC), ...
YouTube-GU Oncology Now
2023/03/09